![]() ![]() ![]() |
Acute normovolemic hemodilution is intentional preoperative
hemodilution induced by the isovolemic exchange of whole blood with colloid
or crystalloid solutions to preserve autologous blood while maintaining
normovolemia.
Intraoperative hemodilution, blood salvage, and retransfusion are appropriate options when large blood loss is expected for a particular surgical procedure, and these are essential adjuncts when treating trauma and shock victims. Preoperative hemodilution however, is performed immediately before or after induction of anesthesia and is common among patients undergoing elective surgery. Hemodilution has been employed during orthopedic procedures, including total hip replacement; major general procedures, including liver resection; and, most extensively, cardiac surgery. If the diverted blood is maintained in continuous contact with the patient's circulation, this can be reinfused later without violating religious beliefs. |
|
1 . Control of initial hematocrit (HTC), heart rate (HR),
mean arterial pressure (MAP, central venous pressure (CVP.
|
|
| "There is no standard nomenclature for degrees of hemodilution,
but it is generally accepted that a hematocrit (HCT) level 28% is hemodilution,
10% is extreme hemodilution, and 15% is profound hemodilution.
Degree of hemodilution varies according to the patient's preoperative condition,
total body surface area, and duration of surgery. Moderate hemodilution
is a safe procedure for patients > 60 years of age, although caution should
be exercised with extreme hemodilution in the elderly. Extreme hemodilution
is better tolerated in young patients, who have a better capacity to maintain
constant circulating blood volume, although it is not suitable for routine
use. Hemodilution is not recommended for patients with coronary artery
disease, significant anemia. renal disease, severe hepatic disease, pulmonary
emphysema, or obstructive lung disease.
During hemodilution. oxygen delivery (D02) is maintained primarily by increased cardiac output. Because blood is a thixotropic fluid, the effects of hemodilution on viscosity are determined in part by shear rates and the characteristics of pulsatile blood flow. During hemodilution, as blood viscosity decreases, resistance to flow of low molecular-weight fluids used for dilution decreases. Decreased fluid viscosity enhances cardiac output and does not jeopardize 02 flow. The maximum reduction in systemic vascular resistance occurs as the HCT level is lowered from 45% to 30%. Lower molecular-weight dextran colloid may improve the distribution of blood flow within peripheral microcirculation with enhanced efficiency of 02 exchange. Maximum 02 transport capacity occurs at a HCT level of 30%. Compensatory mechanisms that result from hemodilution include increased overall blood flow rates, increased 02 extraction, and reduced affinity of 02 to hemoglobin (Hb) that shifts the dissociation curve to the right. As long as the patient remains well oxygenated, increase in cardiac output compensates for the decrease in Hb concentration. The hemodynamic properties of blood are improved by reduced HCT values, and, provided the compensatory mechanisms are intact, tissue perfusion and oxygenation are not adversely affected. Even at levels of profound hemodilution, oxygen extraction increases and 02 consumption remains at near-normal levels. Preservation of D02 during hemodilution is predicated on the assumption that normovolemia be maintained -a caveat that cannot be overemphasized. Extremely low HCT levels (< 15%) are tolerable when hypovolemia is rigorously avoided. The degree of control exercised in an experimental setting cannot necessarily be achieved under operating room conditions. When moderate to profound hemodilution is coupled with any degree of hypovolemia, decompensation occurs and cardiac output may fall precipitously. During hemodilution, blood is withdrawn pre- or intraoperatively, collected in standard bags, and stored as citrate phosphate dextrose (CPD) blood at room temperature. This process preserves the integrity of red blood cells and clotting factors and ensures the availability of safe, fresh, autologous blood for postoperative reinfusion. Neither special equipment nor personnel are required for ANH or retransfusion, and there are no delays for repeated phlebotomy. Operating time is often decreased. which ultimately results in reduced intraoperative blood loss. Other benefits of ANH include postoperative improvements in pulmonary, renal. and myocardial function". _________________________ Extract from "Alternatives to Allogenic Blood Use in
Surgery: Acute Normovolemic Hemodiluition and Preoperative Autologous Donation";
D'Ambra MN and Kaplan DK, The American Journal of Surgery, Vol.170,
N°6A (suppl.), December 1995
|